{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T15:33:52Z","timestamp":1773416032434,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,3,28]],"date-time":"2019-03-28T00:00:00Z","timestamp":1553731200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Rheumatol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s42358-019-0057-9","type":"journal-article","created":{"date-parts":[[2019,3,28]],"date-time":"2019-03-28T08:03:22Z","timestamp":1553760202000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Risk of digital ulcers occurrence in systemic sclerosis: a cross-sectional study"],"prefix":"10.1186","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5137-7719","authenticated-orcid":false,"given":"Alex Magno Coelho","family":"Horimoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert Schiaveto","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia Helena","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristiane","family":"Kayser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,28]]},"reference":[{"key":"57_CR1","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1172\/JCI31139","volume":"117","author":"J Varga","year":"2007","unstructured":"Varga J, Abraham D. Systemic sclerosis: a prototypic multisystem fibrotic disorder. J Clin Invest. 2007;117:557\u201367.","journal-title":"J Clin Invest"},{"key":"57_CR2","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/ar402","volume":"4","author":"AL Herrick","year":"2002","unstructured":"Herrick AL, Worthington J. Genetic epidemiology systemic sclerosis. Arthritis Res. 2002;4:165\u20138.","journal-title":"Arthritis Res"},{"key":"57_CR3","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s12016-009-8193-3","volume":"40","author":"M Geyer","year":"2011","unstructured":"Geyer M, M\u00fcller-Ladner U. The pathogenesis of systemic sclerosis revisited. Clinic Rev Allerg Immunol. 2011;40:92\u2013103.","journal-title":"Clinic Rev Allerg Immunol"},{"key":"57_CR4","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/cmi.2010.78","volume":"8","author":"F Meda","year":"2011","unstructured":"Meda F, Folci M, Baccarelli A, Selmi C. The epigenetics of autoimmunity. Cell Mol Immunol. 2011;8:226\u201336.","journal-title":"Cell Mol Immunol"},{"key":"57_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/rheumatology\/ken481","volume":"48","author":"DJ Abraham","year":"2009","unstructured":"Abraham DJ, Krieg T, Distler J, Distler O. Overview of pathogenesis of systemic sclerosis. Rheumatol. 2009;48:3\u20137.","journal-title":"Rheumatol"},{"key":"57_CR6","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1111\/j.1582-4934.2010.01027.x","volume":"14","author":"M Manetti","year":"2010","unstructured":"Manetti M, Guiducci S, Ibba-Manneschi L, Matucci-Cerinic M. Mechanisms in the loss of capillaries in systemic sclerosis: angiogenesis versus vasculogenesis. J Cell Mol Med. 2010;14:1241\u201354.","journal-title":"J Cell Mol Med"},{"key":"57_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/ar2187","volume":"9","author":"AE Koch","year":"2007","unstructured":"Koch AE, Distler O. Vasculopathy and disordered angiogenesis in selected rheumatic diseases: rheumatoid arthritis and systemic sclerosis. Arthritis Res Ther. 2007;9:1\u20139.","journal-title":"Arthritis Res Ther"},{"key":"57_CR8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1093\/rheumatology\/kep105","volume":"48","author":"V Steen","year":"2009","unstructured":"Steen V, Denton CP, Pope JE, Matucci-Cerinic M. Digital ulcers: overt vascular disease in systemic sclerosis. Rheumatology. 2009;48:19\u201324.","journal-title":"Rheumatology."},{"key":"57_CR9","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3109\/03009742.2013.780095","volume":"42","author":"H Ennis","year":"2013","unstructured":"Ennis H, Vail A, Wragg E, Taylor A, Moore T, Murray A, et al. A prospective study of systemic sclerosis-related digital ulcers: prevalence, location, and functional impact. Scand J Rheumatol. 2013;42:483\u20136.","journal-title":"Scand J Rheumatol"},{"key":"57_CR10","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1002\/acr.20342","volume":"63","author":"A B\u00e9rezn\u00e9","year":"2011","unstructured":"B\u00e9rezn\u00e9 A, Seror R, Morell-Dubois S, de Menthon M, Fois E, Dzeing-Ella A. Impact of systemic sclerosis on occupational and professional activity with attention to patients with digital ulcers. Arthritis Care Res. 2011;63:277\u201385.","journal-title":"Arthritis Care Res"},{"key":"57_CR11","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1136\/annrheumdis-2011-200631","volume":"71","author":"CP Denton","year":"2012","unstructured":"Denton CP, Krieg T, Guillevin L. Demographic, clinical and antibody characteristics of patients with digital ulcers in systemic sclerosis: data from the DUO registry. Ann Rheum Dis. 2012;71:718\u201321.","journal-title":"Ann Rheum Dis"},{"key":"57_CR12","first-page":"127","volume":"33","author":"I Silva","year":"2015","unstructured":"Silva I, Teixeira A, Oliveira J, Almeida I, Almeida R, Vasconcelos C. Predictive value of vascular disease biomarkers for digital ulcers in systemic sclerosis patients. Clin Exp Rheumatol. 2015;33:127\u201330.","journal-title":"Clin Exp Rheumatol"},{"key":"57_CR13","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1136\/ard.2010.132431","volume":"70","author":"V Smith","year":"2011","unstructured":"Smith V, De Keyser F, Pizzorni C, Van Praet JT, Decuman S, Sulli A, et al. Nailfold capillaroscopy for day-to-day clinical use: construction of a simple scoring modality as a clinical prognostic index for digital trophic lesions. Ann Rheum Dis. 2011;70:180\u20133.","journal-title":"Ann Rheum Dis"},{"key":"57_CR14","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1002\/art.39718","volume":"68","author":"M Cutolo","year":"2016","unstructured":"Cutolo M, Herrick AL, Distler O, Becker MO, Beltran E, Carpentier P, et al. Nailfold Videocapillaroscopic features and other clinical risk factors for digital ulcers in systemic sclerosis. Arthritis Rheum. 2016;68:2527\u201339.","journal-title":"Arthritis Rheum"},{"key":"57_CR15","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.semarthrit.2017.02.006","volume":"47","author":"J Avouac","year":"2017","unstructured":"Avouac J, Lepri G, Smith V, Toniolo E, Hurabielle C, Vallet A, et al. Sequential nailfold videocapillaroscopy examinations have responsiveness to detect organ progression in systemic sclerosis. Semin Arthritis Rheum. 2017;47:86\u201394.","journal-title":"Semin Arthritis Rheum"},{"key":"57_CR16","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3233\/CH-141809","volume":"59","author":"A Manfredi","year":"2015","unstructured":"Manfredi A, Sebastiani M, Carraro V, Iudici M, Bocci M, Vukatana G, et al. Prediction risk chart for scleroderma digital ulcers: a composite predictive model based on capillaroscopic, demographic and clinico-serological parameters. Clin Hemorheol Microcirc. 2015;59:133\u201343.","journal-title":"Clin Hemorheol Microcirc"},{"key":"57_CR17","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1093\/rheumatology\/kew047","volume":"56","author":"M Hughes","year":"2017","unstructured":"Hughes M, Herrick AL. Digital ulcers in systemic sclerosis. Rheumatology. 2017;56:14\u201325.","journal-title":"Rheumatology"},{"key":"57_CR18","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1002\/art.38098","volume":"65","author":"F Hoogen van den","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative. Arthritis Rheum. 2013;65:2737\u201347.","journal-title":"Arthritis Rheum"},{"key":"57_CR19","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jacc.2013.10.032","volume":"62","author":"MM Hoeper","year":"2013","unstructured":"Hoeper MM, Bogaard HJ, Condliffe R, Frantz R, Khanna D, Kurzyna M, et al. Definitions and diagnosis of pulmonary hypertension. J Am Coll Cardiol. 2013;62:42\u201350.","journal-title":"J Am Coll Cardiol"},{"key":"57_CR20","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1136\/ard.62.9.904","volume":"62","author":"G Valentini","year":"2003","unstructured":"Valentini G, D\u2019Angelo S, Rossa AD, Bencivelli W, Bombardieri S. European scleroderma study group to define disease activity criteria for systemic sclerosis. IV. Assessment of skin thickening by modified Rodnan skin score. Ann Rheum Dis. 2003;62:904\u20135.","journal-title":"Ann Rheum Dis"},{"key":"57_CR21","first-page":"202","volume":"15","author":"EC LeRoy","year":"1988","unstructured":"LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol. 1988;15:202\u20135.","journal-title":"J Rheumatol"},{"key":"57_CR22","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1002\/art.10486","volume":"46","author":"PA Merkel","year":"2002","unstructured":"Merkel PA, Herlyn K, Martin RW, Anderson JJ, Mayes MD, Bell P, et al. Scleroderma clinical trials consortium. Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon. Arthritis Rheum. 2002;46:2410\u201320.","journal-title":"Arthritis Rheum"},{"key":"57_CR23","first-page":"2159","volume":"26","author":"TA Medsger Jr","year":"1999","unstructured":"Medsger TA Jr, Silman AJ, Steen VD, Black CM, Akesson A, Bacon PA, et al. A disease severity scale for systemic sclerosis: development and testing. J Rheumatol. 1999;26:2159\u201367.","journal-title":"J Rheumatol"},{"key":"57_CR24","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/art.22468","volume":"57","author":"F Rannou","year":"2007","unstructured":"Rannou F, Poiraudeau S, Berezn\u00e9 A, Baubet T, Le-Guern V, Cabane J, et al. Assessing disability and quality of life in systemic sclerosis: construct validities of the Cochin hand function scale, health assessment questionnaire (HAQ), systemic sclerosis HAQ, and medical outcomes study 36-item short form health survey. Arthritis Rheum. 2007;57:94\u2013102.","journal-title":"Arthritis Rheum"},{"key":"57_CR25","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1093\/rheumatology\/keq097","volume":"49","author":"L Amanzi","year":"2010","unstructured":"Amanzi L, Braschi F, Fiori G, Galluccio F, Miniati I, Guiducci S, et al. Digital ulcers in scleroderma: staging, characteristics and sub-setting through observation of 1614 digital lesions. Rheumatology. 2010;49:1374\u201382.","journal-title":"Rheumatology"},{"key":"57_CR26","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1002\/acr.22054","volume":"65","author":"JY Sekiyama","year":"2013","unstructured":"Sekiyama JY, Camargo CZ, Andrade LE, Kayser C. Reliability of Widefield Nailfold Capillaroscopy and Videocapillaroscopy in the assessment of patients with Raynaud's phenomenon. Arthritis Care Res. 2013;65:1853\u201361.","journal-title":"Arthritis Care Res"},{"key":"57_CR27","volume-title":"Essential statistics for the pharmaceutical sciences. Chichester","author":"P Rowe","year":"2007","unstructured":"Rowe P. Essential statistics for the pharmaceutical sciences. Chichester. England: John Wiley & Sons Ltda; 2007."},{"key":"57_CR28","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1136\/annrheumdis-2011-200780","volume":"71","author":"V Smith","year":"2012","unstructured":"Smith V, Decuman S, Sulli A, Bonroy C, Piettte Y, Deschepper E, et al. Do worsening scleroderma capillaroscopic patterns predict future severe organ involvement? A pilot study. Ann Rheum Dis. 2012;71:1636\u20139.","journal-title":"Ann Rheum Dis"},{"key":"57_CR29","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1093\/rheumatology\/ket386","volume":"53","author":"H Ennis","year":"2014","unstructured":"Ennis H, Moore T, Murray A, Vail A, Herrick AL. Further confirmation that digital ulcers are associated with the severity of abnormality on nailfold capillaroscopy in patients with systemic sclerosis. Rheumatology. 2014;53:376\u20137.","journal-title":"Rheumatology"},{"key":"57_CR30","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1002\/art.24394","volume":"61","author":"M Sebastiani","year":"2009","unstructured":"Sebastiani M, Manfredi A, Colaci M, D'amico R, Malagoli V, Giuggioli D, et al. Capillaroscopic skin ulcer risk index: a new prognostic tool for digital skin ulcer development in systemic sclerosis patients. Arthritis Rheum. 2009;61:688\u201394.","journal-title":"Arthritis Rheum"},{"key":"57_CR31","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1136\/annrheumdis-2011-200022","volume":"71","author":"M Sebastiani","year":"2012","unstructured":"Sebastiani M, Manfredi A, Vukatana G, Moscatelli S, Riato L, Bocci M, et al. Predictive role of capillaroscopic skin ulcer risk index in systemic sclerosis: a multicentre validation study. Ann Rheum Dis. 2012;71:67\u201370.","journal-title":"Ann Rheum Dis"},{"key":"57_CR32","first-page":"42","volume":"21","author":"TA Medsger","year":"2003","unstructured":"Medsger TA, Bombardieri S, Czirjak L, Scorza R, Della Rossa A, Bencivelli W. Assessment of disease severity and prognosis. Clin Exp Rheumatol. 2003;21:42\u20136.","journal-title":"Clin Exp Rheumatol"},{"key":"57_CR33","first-page":"367","volume":"25","author":"Y Morita","year":"2007","unstructured":"Morita Y, Muro Y, Sugiura K, Tomita Y, Tamakoshi K. Results of the health assessment questionnaire for Japanese patients with systemic sclerosis \u2013 measuring functional impairment in systemic sclerosis versus other connective tissue diseases. Clin Exp Rheumatol. 2007;25:367\u201372.","journal-title":"Clin Exp Rheumatol"},{"key":"57_CR34","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0889-857X(03)00023-1","volume":"29","author":"TA Medsger Jr","year":"2003","unstructured":"Medsger TA Jr. Natural history of systemic sclerosis and the assessment of disease activity, severity, functional status, and psychologic well-being. Rheum Dis Clin N Am. 2003;29:255\u201373.","journal-title":"Rheum Dis Clin N Am"},{"key":"57_CR35","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s11926-010-0140-z","volume":"13","author":"G Abignano","year":"2011","unstructured":"Abignano G, Buch M, Emery P, Galdo FD. Biomarkers in the management of scleroderma: an update. Curr Rheumatol Rep. 2011;13:4\u201312.","journal-title":"Curr Rheumatol Rep"},{"key":"57_CR36","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.3899\/jrheum.081044","volume":"36","author":"KP Tiev","year":"2009","unstructured":"Tiev KP, Diot E, Clerson P, Dupuis-Sim\u00e9on F, Hachulla E, Hatron PY, et al. Clinical features of scleroderma patients with or without prior or current ischemic digital ulcers: post-hoc analysis of a nationwide multicenter cohort (Itin\u00e9rAIR-Scl\u00e9rodermie). J Rheumatol. 2009;36:1470\u20136.","journal-title":"J Rheumatol"},{"key":"57_CR37","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1002\/acr.20336","volume":"63","author":"S Khimdas","year":"2011","unstructured":"Khimdas S, Harding S, Bonner A, Zummer B, Baron M, Pope J. Associations with digital ulcers in a large cohort of systemic sclerosis: results from the Canadian scleroderma research group registry. Arthritis Care Res. 2011;63:142\u20139.","journal-title":"Arthritis Care Res"},{"key":"57_CR38","doi-asserted-by":"publisher","first-page":"32","DOI":"10.4274\/tjh.2012.0059","volume":"30","author":"AO Tour\u00e9","year":"2013","unstructured":"Tour\u00e9 AO, Ly F, Sall A, Diatta A, Gadji M, Seck M, et al. Antiphospholipid antibodies and systemic scleroderma. Turk J Haematol. 2013;30:32\u20136.","journal-title":"Turk J Haematol"},{"key":"57_CR39","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1136\/ard.2005.038430","volume":"64","author":"G Sanna","year":"2005","unstructured":"Sanna G, Bertolaccini ML, Mameli A, Hughes GRV, Khamashta MA, Mathieu A. Antiphospholipid antibodies in patients with scleroderma: prevalence and clinical significance. Ann Rheum Dis. 2005;64:1795\u20136.","journal-title":"Ann Rheum Dis"},{"key":"57_CR40","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.autrev.2011.04.007","volume":"10","author":"L Iaccarino","year":"2011","unstructured":"Iaccarino L, Ghirardello A, Canova M, Zen M, Bettio S, Nalotto L, et al. Anti-annexins autoantibodies: their role as biomarkers of autoimmune diseases. Autoimm Rev. 2011;10:553\u20138.","journal-title":"Autoimm Rev"}],"container-title":["Advances in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s42358-019-0057-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s42358-019-0057-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s42358-019-0057-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,27]],"date-time":"2020-03-27T00:20:53Z","timestamp":1585268453000},"score":1,"resource":{"primary":{"URL":"https:\/\/advancesinrheumatology.biomedcentral.com\/articles\/10.1186\/s42358-019-0057-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,28]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["57"],"URL":"https:\/\/doi.org\/10.1186\/s42358-019-0057-9","relation":{},"ISSN":["2523-3106"],"issn-type":[{"value":"2523-3106","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,28]]},"assertion":[{"value":"20 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The manuscript was approved by the institutional ethical review board by both institutions, in their respective ethics committees:Federal University of S\u00e3o Paulo opinion number: 1.433.963 CAAE: 53429216.5.1001.5505.Federal University of Mato Grosso do Sul: 1.300.296.CAAE: 49087115.6.0000.0021.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All subjects signed informed consent approved by the institutional ethical review board by both institutions.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"14"}}